Reductions seen in office systolic blood pressure for those in no-CKD, stage 3a CKD, and stage 3b CKD groups. (HealthDay News) — Radiofrequency renal denervation (RDN) yields a clinically meaningful ...
In the no-CKD and stage 3a groups, the burden of antihypertensive medication remained high, but it declined in the CKD stage 3b group over three years. "RDN is likely to be safe and may represent an ...
RADNOR, Pa., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...
March is National Kidney Month, a time to raise awareness about the importance of kidney health and the need for comprehensive screening to close gaps in care, especially for those living with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results